Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | JNJ 38877605 |
| Trade Name | |
| Synonyms | JNJ38877605|JNJ-38877605 |
| Drug Descriptions |
JNJ 38877605 binds to MET and prevents its activation, resulting in decreased downstream signaling and potentially resulting in increased cell death of MET-overexpressing tumor cells (PMID: 31881189, PMID: 30284817). |
| DrugClasses | MET Inhibitor 59 |
| CAS Registry Number | 943540-75-8 |
| NCIT ID | C77893 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cetuximab + JNJ 38877605 | Cetuximab JNJ 38877605 | 0 | 0 |
| JNJ 38877605 | JNJ 38877605 | 0 | 0 |
| JNJ 38877605 + Olaparib | JNJ 38877605 Olaparib | 0 | 0 |
| JNJ 38877605 + Panitumumab | JNJ 38877605 Panitumumab | 0 | 0 |